The prevalence of CHEK2 and CYP1B1 mutations/polymorphisms in urinary bladder cancer
Main Authors: | Banaszkiewicz Monika, Constantinou Maria, Pietrusiński Michał, Kępczyński Łukasz, Jędrzejczyk Adam, Rożniecki Marek, Marks Piotr, Kałużewski Bogdan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | Hereditary Cancer in Clinical Practice |
Online Access: | http://www.hccpjournal.com/content/10/S4/A20 |
Similar Items
-
Artificial neural network in predicting bladder cancer recurrence
by: Borkowska Edyta, et al.
Published: (2012-01-01) -
The A148T variant of <it>CDKN2A</it> gene in bladder cancer
by: Borkowska E, et al.
Published: (2011-06-01) -
The Usefulness of Cell-Based and Liquid-Based Urine Tests in Clarifying the Diagnosis and Monitoring the Course of Urothelial Carcinoma. Identification of Novel, Potentially Actionable, <i>RB1</i> and <i>ERBB2</i> Somatic Mutations
by: Tadeusz Kałużewski, et al.
Published: (2021-04-01) -
Germline Mutations in CHEK1 and CHEK2 in Women with Ovarian, Peritoneal, or Fallopian Tube Cancer
by: Harrell, Maria Isabel
Published: (2015) -
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
by: Chunyan Gu, et al.
Published: (2021-06-01)